China Isotope & Radiation Corp. (HK:1763) has released an update.
China Isotope & Radiation Corporation has announced that its subsidiary, CNNC Accuray, has obtained a registration certificate from China’s National Medical Products Administration for Precision, the therapy planning system of its high-end TomoTherapy system. This system promises enhanced tomography planning functions, efficiency, and patient experience, delivering more personalized therapy services. The development marks a significant advancement for the company in providing integrated medical technology solutions.
For further insights into HK:1763 stock, check out TipRanks’ Stock Analysis page.
